Hain Celestial has booked improved second-quarter sales and earnings, boosted by the performance of its international and protein units.
The company said net sales rose 8% in the three months to the end of December, rising to US$752.6m. The group’s top line performance accelerated in the second quarter. For the first half, sales rose at the slightly slower pace of 7.1%.
Excluding currency exchange, second-quarter sales were up 11% thanks to an increase in revenue from its overseas and protein divisions of 12% and 21% on a constant-currency basis. The results were partially offset by a 4.7% drop in US sales during the three-month period.
Operating income stood at $87.7m, versus $74m a year ago. Adjusted for factors including M&A, restructuring and integration charges, second-quarter adjusted operating income reached $92.9m, against $87.4m a year earlier.
Adjusted operating margins dipped, falling from 12.5% to 12.3% a year ago. However, Hain Celestial did see this margin metric improve quarter on quarter. In the first three months of the year, its adjusted operating margin was 9.1%.
Net income increased to $56.9m in the quarter compared to $44.5m last year. For the half, net earnings increased to $88.2m versus $63.4m.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
Looking to the full year, Hain Celestial reaffirmed its forecast for sales of $2.9-3.04bn – up 7-12% – and for earnings of $1.95 to $2.10 per share, up 4-12%.